| Open Document File Size: 420,86 KBShare Result on Facebook
City BCAP / / Company IgG / Giltiay NV / BioMed Central Ltd / / / Event FDA Phase / Product Issues / / Facility BM checkpoint / University of Washington / / IndustryTerm microtubular networks / therapies for SLE / therapeutics for rheumatic diseases / treatment of autoimmune diseases / Treatment of SLE / therapies for autoimmune diseases / / MedicalCondition SLE-like disease / autoimmune disorders / spontaneous SLE-like disease / systemic lupus erythematosus / lymphocytic leukemia / lupuslike disease / T-cell-independent lupuslike disease / disease / SLE disease / B-cell cancers / human autoimmune disorders / lupus-like disease / Arthritis / chronic lymphocytic leukemia / rheumatoid arthritis / rheumatic diseases / spontaneous diabetes / active SLE disease / diabetes / myeloproliferative syndrome / collagen-induced arthritis / viral infections / also delayed disease / particular autoimmune disorders / established skin disease / Sjögren’s syndrome / autoimmune disease / certain autoimmune disorders / diseases / bacterial infection / acute systemic autoimmune disease / significant autoimmune disease / glomerulonephritis / SLE / lupus / autoimmune thyroiditis / human lupus / autoimmune diseases / / MedicalTreatment immunotherapies / AID / / MusicGroup Yes / / Organization Department of Immunology / University of Washington / Seattle / / Person Edward A Clark / / Position author / / Product central tolerance / Syk / BCR signaling / SLE / / ProvinceOrState Washington / / Technology cell receptors / antibodies / gene expression / cell signaling / genotype / recombination / apoptosis / / URL http /
SocialTag |
Giltiay et al. Arthritis Research & Therapy 2012, 14(Suppl 4):S1 http://arthritis-research.com/content/14/S4/S1 REVIEW B-cell selection and the development of